United States · FDA National Drug Code directory

ACETAMINOPHEN PM

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
17714-133_60f41580-e074-faad-e053-2a91aa0a9076
Product NDC
17714-133
Form
TABLET
Composition / generic term
ACETAMINOPHEN PM
Labeler
Advance Pharmaceutical Inc.
Marketing category
OTC MONOGRAPH FINAL
Marketing start / end (source format)
20020109
Source listing expiry
20261231

Source-listed ingredients

  • ACETAMINOPHEN — 500 mg/1
  • DIPHENHYDRAMINE HYDROCHLORIDE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 50 TABLET in 1 BOTTLE (17714-133-50) · 17714-133-50

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
ACETAMINOPHEN PM — United States | Molindra Medicines